Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology
Reference66 articles.
1. Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer
2. CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin
3. Extracting the normal lung dose–response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance
4. Optimal fractionation in radiotherapy for non-small cell lung cancer – a modelling approach
5. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Empowering radiotherapy: Harnessing nanomedicines to enhance radiation response and boost antitumor efficacy;Coordination Chemistry Reviews;2024-12
2. Differential regulation of radio-sensitivity/macrophage polarization in intestinal tissue and colorectal cancer for the optimized preoperative radiotherapy;Chemical Engineering Journal;2024-10
3. A pH transformable nanocarrier for gradual and precise delivery of a natural immunomodulator and chemotherapy agent to trigger tumor apoptosis;Chemical Engineering Journal;2024-09
4. Blocking ACSL6 Compromises Autophagy via FLI1‐Mediated Downregulation of COLs to Radiosensitize Lung Cancer;Advanced Science;2024-08-29
5. Laser-enzyme dual responsive liposomes to regulate autophagy in synergy with phototherapy for melanoma treatment;Journal of Drug Targeting;2024-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3